Cancer stem cells (CSCs) are cancer cells (found within tumors or hematological cancers) that possess characteristics associated with normal stem cells, specifically the ability to give rise to all cell types found in a particular cancer sample.
This report contains market size and forecasts of Cancer Stem Cells in Global, including the following market information:
- Global Cancer Stem Cells Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Cancer Stem Cells market was valued at 883.8 million in 2021 and is projected to reach US$ 1894 million by 2028, at a CAGR of 11.5% during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Cell Culturing Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Cancer Stem Cells include Thermo Fisher Scientific, Abbvie, Merck Kgaa, Bionomics, Lonza, Stemline Therapeutics, Miltenyi Biotec, Promocell and Macrogenics, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Cancer Stem Cells companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Cancer Stem Cells Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Cancer Stem Cells Market Segment Percentages, by Type, 2021 (%)
- Cell Culturing
- Cell Separation
- Cell Analysis
- Molecular Analysis
- Others
Global Cancer Stem Cells Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Cancer Stem Cells Market Segment Percentages, by Application, 2021 (%)
- Breast Cancer Diagnosis and Treatment
- Prostate Cancer Diagnosis and Treatment
- Colorectal Cancer Diagnosis and Treatment
- Lung Cancer Diagnosis and Treatment
- Others
Global Cancer Stem Cells Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Cancer Stem Cells Market Segment Percentages, By Region and Country, 2021 (%)
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Nordic Countries
- Benelux
- Rest of Europe
- Asia
- China
- Japan
- South Korea
- Southeast Asia
- India
- Rest of Asia
- South America
- Brazil
- Argentina
- Rest of South America
- Middle East & Africa
- Turkey
- Israel
- Saudi Arabia
- UAE
- Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
- Key companies Cancer Stem Cells revenues in global market, 2017-2022 (estimated), ($ millions)
- Key companies Cancer Stem Cells revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
- Thermo Fisher Scientific
- Abbvie
- Merck Kgaa
- Bionomics
- Lonza
- Stemline Therapeutics
- Miltenyi Biotec
- Promocell
- Macrogenics
- Oncomed Pharmaceuticals
- Irvine Scientific
- Stemcell Technologies
- Sino Biological
- Biotime
